Bookmark

Add to MyYahoo RSS

Pharmacyclics News

News on Pharmacyclics (Ticker: PCYC) continually updated from thousands of sources around the net.

16 hrs ago | Sys-Con Media

The Zacks Analyst Blog Highlights:GIlead, AbbVie, MannKind, Alkermes and Pharmacyclics

Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Alkermes, Gilead Sciences, MannKind, Startups, Financial Markets, Science / Technology

21 hrs ago | Seeking Alpha

Individual Investor Portfolio Update: Rebalanced And Geared Up For The Long-Term

Sufficient cash is available in the event a market correction occurs in the near-term, or other opportunities present themselves.

3 comments

Related Topix: IRA, Personal Finance, Baidu, eBay, Startups, Industrial Machines, Precision Castparts, Aerospace-Defense, Metals, Transportation, Trucking, United Parcel Service, Air Courier

Wed Apr 16, 2014

Hispanic Business

Pharmacyclics Files Supplemental New Drug Application for Imbruvica with Phase III CLL Study Data

IMBRUVICA is being jointly developed and commercialized by , the results of the RESONATE study demonstrated a statistically significant improvement in progression-free survival, the primary endpoint of the study, in patients treated with IMBRUVICA.

Comment?

Related Topix: Healthcare Law, Law, Startups, Leukemia, Health, Lymphoma

Forbes.com

A Lucky Drug Made Pharmacyclics' Robert Duggan A Billionaire. Will Long-Term Success Follow?

Robert Duggan was enjoying just your average Tampa vacation-a visit to the headquarters of the Church of Scientology, to which he's a major donor, and a double date with one of the world's top supermodels-when a board member at Pharmacyclics , a biotechnology company he had invested in, interrupted the party with some urgent news.

Comment?

Related Topix: Startups, Religion, Scientology, Biotech, Science / Technology, Healthcare Law, Law, Business News

Tue Apr 08, 2014

The Motley Fool

Today's Top Biotech Stories: Takeda, Eli Lilly, Immunomedics, and Pharmacyclics

Takeda Pharmaceutical and Eli Lilly have just been ordered to pay a combined $9 billion in punitive damages, after a Louisiana court ruled that the companies intentionally hid the cancer risks of their diabetes drug, Actos.

Comment?

Related Topix: Biotech, Startups, Medicine, Healthcare Industry, Immunomedics, Eli Lilly, Cancer, Health, Diabetes

AmericanBankingNews.com

Pharmacyclics Receives Average Recommendation of "Buy" from Brokerages

Shares of Pharmacyclics have earned an average rating of "Buy" from the seventeen analysts that are presently covering the company, Stock Ratings News reports .

Comment?

Related Topix: Startups, Stanley

Sys-Con Media

Supplemental New Drug Application for IMBRUVICAa (ibrutinib) Submitted to the U.S. FDA

IMBRUVICA is being jointly developed and commercialized by Janssen and Pharmacyclics.

Comment?

Related Topix: Healthcare Law, Law, Food and Drug Administration, Startups, Leukemia, Health, Lymphoma, Oncology, Medicine

Tue Apr 01, 2014

MarketNewsVideo

Tuesday's ETF Movers: BBH, IDU

In trading on Tuesday, the Biotech ETF is outperforming other ETFs, up about 2.3% on the day.

Comment?

Related Topix: Startups, Biotech, Celgene, Medicine, Healthcare Industry, Business News, Video

Mon Mar 31, 2014

TheStreet.com

Three Oversold BioTechs for Tired Gamblers: StockTwits.com

NEW YORK -- Investing in the biotech sector this past year has been akin to playing all-in blackjack with the FDA as dealer.

Comment?

Related Topix: Biotech, Science / Technology, TheStreetcom, Media, TheStreet, Computers, Games, Blackjack, Food and Drug Administration, Startups

Fri Mar 28, 2014

BayStreet.ca

RDInvesting Provides Investors with Free In-Depth Equity Reports on...

Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events.

Comment?

Related Topix: Biotech, ICON, Startups, Stanley

Sys-Con Media

Biotech Stocks Analysis -- Research on Array BioPharma, ACADIA Pharma, Pharmacyclics, and Isis Pharma

The losses were broad based as nine out of 10 sectors ended the session in negative.

Comment?

Related Topix: Biotech, Medicine, Array BioPharma, Healthcare Industry, Startups, Financial Markets, Isis Pharmaceuticals

Thu Mar 27, 2014

Silicon Alley Insider

Morgan Stanley Just Published A Huge Biotech Stock Report Forecasting ...

Investors and traders have been chattering about biotech stocks lately. Even after a recent 10% drop, the sector is still up by around 200% since its bull market began in 2011.

Comment?

Related Topix: Financial Markets, Amgen, Celgene, Startups

Thu Mar 20, 2014

Investor's Business Daily

Pharmacyclics Drug Imbruvica Beats Rivals: Nomura

Somaiya wrote that his survey of 30 doctors treating more than 1,600 CLL patients "highlighted rapid transition of the CLL market to newer oral drugs, in particular PCYC's Imbruvica," which was launched by Pharmacyclics and He wrote that the doctors generally thought Imbruvica is better than idelalisib, Gilead's drug that is awaiting approval, but ... (more)

Comment?

Related Topix: Startups

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••
•••